Publications from TNU

Sort by: Date | Author | Title

Smedegaard, S. B., Mose, M., Hulman, A., Mikkelsen, U. R., Møller, N., Wegener, G., Jessen, N. & Rittig, N. (2021). β-Lactoglobulin Elevates Insulin and Glucagon Concentrations Compared with Whey Protein-A Randomized Double-Blinded Crossover Trial in Patients with Type Two Diabetes Mellitus. Nutrients, 13(2), Article 308. https://doi.org/10.3390/nu13020308

Slattery, D. A., Finger, B. C., Maloumby, R., Wegener, G., Mathé, A. A. & Neumann, I. D. (2008). Neuropeptide S alters affective behaviour in high (HAB) but not low anxiety-related (LAB) rats. Abstract from Society for Neuroscience, Congress 2008, Washington, United States.

Slattery, D. A., Naik, R. R., Grund, T., Yen, Y.-C., Sartori, S. B., Füchsl, A., Finger, B. C., Elfving, B., Nordemann, U., Guerrini, R., Calo, G., Wegener, G., Mathé, A. A., Singewald, N., Czibere, L., Landgraf, R. & Neumann, I. D. (2015). Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity. The Journal of neuroscience : the official journal of the Society for Neuroscience, 35(11), 4599-613. https://doi.org/10.1523/JNEUROSCI.4764-13.2015

Sinning, S. (2005). Characterisation of the ligand binding site of the human serotonin transporter.

Sinning, S., Severinsen, K., Hansen, C. G., Celik, L., Musgaard, M., Koldsø, H., Schiøtt, B., Rosenberg, R. & Wiborg, O. (2006). An experimentally supported homology model for the antidepressant binding site on the human serotonin transporter: Poster. In 2006 Neuroscience Meeting Planner (Vol. 531.6/E24)

Sinning, S., Celik, L., Severinsen, K., Hansen, C. G., Wiborg, O. & Schiøtt, B. (2006). Homology modeling of the human serotonin transporter structure and the substrate binding site. In 2006 Neuroscience Meeting Planner (Vol. 531.7/E25)

Sinning, S., Christensen, H. S., Boye, S. V., Thingaard, J., Wiborg, O., Schiøtt, B. & Bols, M. (2007). QSAR studies and pharmacophore identification for acrylsubstituted cycloalkenecarboxylic acid methyl esters with affinity for the human dopamine transporter. Bioorganic & Medicinal Chemistry, 15, 5262-5274. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TF8-4NP97YG-1&_user=10&_coverDate=08%2F01%2F2007&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5e8a47e7dd2ba3f9d84d87fb2e924327&searchtype=a

Sinning, S., Petersen, M. D., Boye, S. V., Nielsen, E. H., Willumsen, J., Wiborg, O. & Bols, M. (2007). Synthesis, inhibition and binding of simple non-nitrogen inhibitors og monoamine transporters. Bioorganic & Medicinal Chemistry, 15(12), 4159-4174. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TF8-4NCJCJR-6&_user=10&_coverDate=06%2F15%2F2007&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=1d3590bd83e0f1723427b7218e96ec5b&searchtype=a

Sinning, S., Boye, S. V., Wiborg, O., Ortega-Caballero, F., Jensen, HH. & Bols, M. (2007). High dopamine transporter selectively can be displayed by remarkably simple non-nitrogen containing inhibitors. Bioorg. Med. Chem. Lett., 17(21), 6019-6025.

Sinning, S. & Severinsen, K. (2008). A Biochemically Validated Induced Fit Docking Model of Phenylpiperazine in a hSERT homology model. Poster session presented at Society for Neuroscience.

Sinning, S., Severinsen, K., Celik, L., Musgaard, M., Koldsø, H., Schiøtt, H. B., Wiborg, O., Hansen, C. G., Jensen, M. & Jensen, H. H. (2008). Tricykliske antidepressivas binding til den humane serotonin transporter. Abstract from Psykiatriens 3. Forskningsdag, Risskov, Denmark.

Sinning, S., Severinsen, K., Hansen, C. G., Celik, L., Musgaard, M., Koldsø, H., Jensen, M., Jensen, H. H., Schiøtt, H. B. & Wiborg, O. (2008). Tricyclic antidepressant binding to the human serotonin transporter. Abstract from Gordon Research Conference, Membrane Transport Proteins, Il Ciocco, Italy.

Sinning, S. (2009). Det vestibulære bindingssteds rolle for allosterisk modulation af antidepressiva bundet til serotonin transporteren. Poster session presented at Psykiatriens Forskningsdag 2009, Århus, Denmark.

Sinning, B. R. & Gade, A. (2009). Depression. In Klinisk Neuropsykologi (pp. 399-419). Frydenlund Academic.

Sinning, B. R. (2009). Neuropsykologi. In Klinisk neuropsykiatri: Fra molekyle til sygdom (1. udgave ed., pp. 79-94). FADL's Forlag.

Sinning, S., Musgaard, M., Jensen, M., Severinsen, K., Celik, L., Koldsoe, H., Meyer, T., Bols, M., Jensen, H. H., Schiøtt, H. B. & Wiborg, O. (2010). Binding and Orientation of Tricyclic Antidepressants within the Central Substrate Site of the Human Serotonin Transporter. Journal of Biological Chemistry, 285(11), 8363-8374. https://doi.org/10.1074/jbc.M109.045401

Sinning, S. & Larsen, M. T. (2013). SERT/NET selectivity of tropane compounds. Poster session presented at 6th SFB35 Symposium, Wien, Austria.

Sinning, S. (2013, Jul 2). ER DE RENE(RE)? http://newsroom.au.dk/aktuelt/tour-de-france/#news-385

Sinning, S., Said, S., Malinauskaite, L., Sahin, C., Grouleff, J., Shahsavar, A., Bjerregaard, H., Noer, P. R., Severinsen, K., Boesen, T., Schiøtt, B. & Nissen, P. (2016). The molecular mechanism for overcoming the rate-limiting step in monoamine neurotransmitter transport. Poster session presented at Gordon Research Conferenc, Barga, Italy.

Sinning, S. & Lund, A. E. (2017). Jungle Brew and Depression:Molecular Pharmacology of Ayahuasca Alkaloids on Monoamine Transporter Systems. Poster session presented at 9th Annual Meeting of the Danish Society of Pharmacology, Odense, Denmark.

Simonsen, C. Z., Østergaard, L., Smith, D. F., Vestergaard-Poulsen, P. & Gyldensted, C. (2000). Comparison of gradient- and spin-echo imaging: CBF, CBV, and MTT measurements by bolus tracking. Journal of Magnetic Resonance Imaging, 12(3), 411-6. https://doi.org/10.1002/1522-2586(200009)12:3<411::AID-JMRI6>3.0.CO;2-5

Simonsen, A., Fusaroli, R., Bliksted, V., Mors, O., Roepstorff, A. & Campbell-Meiklejohn, D. (2018). INTEGRATION OF SENSORY AND SOCIAL INFORMATION DURING DECISION MAKING IN SCHIZOPHRENIA. Schizophrenia Bulletin, 44(suppl 1), S350-S350. https://doi.org/10.1093/schbul/sby018.854

Silveira, K. M., Wegener, G. & Joca, S. R. L. (2021). Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression. Basic & Clinical Pharmacology & Toxicology, 129(1), 3-14. https://doi.org/10.1111/bcpt.13595

Silveira, K. M., Sartim, A. G., Vieira, L., Lisboa, S. F., Wegener, G. & Joca, S. R. L. (2023). Decreased sensitivity to antidepressant drugs in Wistar Hannover rats submitted to two animal models of depression. Acta Neuropsychiatrica, 35(1), 35-49. https://doi.org/10.1017/neu.2022.24

Silva Pereira, V., Elfving, B., Joca, S. R. L. & Wegener, G. (2017). Ketamine and aminoguanidine differentially affect Bdnf and Mtor gene expression in the prefrontal cortex of adult male rats. European Journal of Pharmacology, 815, 304-311. https://doi.org/10.1016/j.ejphar.2017.09.029

Silote, G. P., Sartim, A., Sales, A., Eskelund, A., Guimarães, F. S., Wegener, G. & Joca, S. (2019). Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. Journal of Chemical Neuroanatomy, 98, 104-116. https://doi.org/10.1016/j.jchemneu.2019.04.006

Silote, G. P., de Oliveira, S. F. S., Ribeiro, D. E., Machado, M. S., Andreatini, R., Joca, S. R. L. & Beijamini, V. (2020). Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 100, Article 109878. https://doi.org/10.1016/j.pnpbp.2020.109878

Silote, G. P., Gatto, M. C., Eskelund, A., Guimarães, F. S., Wegener, G. & Joca, S. R. L. (2021). Strain-, sex-, and time-dependent antidepressant-like effects of cannabidiol. Pharmaceuticals, 14(12), Article 1269. https://doi.org/10.3390/ph14121269

Silote, G. (2021). Behavioural and molecular effects induced by Cannabidiol in animal models of depression.

Sigvard, A. K., Nielsen, M. Ø., Gjedde, A., Bojesen, K. B., Fuglø, D., Tangmose, K., Kumakura, Y., Heltø, K., Ebdrup, B. H., Jensen, L. T., Rostrup, E. & Glenthøj, B. Y. (2022). Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial DopamineD₂ Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response. Biological Psychiatry, 91(2), 236-245. https://doi.org/10.1016/j.biopsych.2021.08.023

Sigvard, A. K., Bojesen, K. B., Ambrosen, K. S., Nielsen, M. Ø., Gjedde, A., Tangmose, K., Kumakura, Y., Edden, R., Fuglø, D., Jensen, L. T., Rostrup, E., Ebdrup, B. H. & Glenthøj, B. Y. (2023). Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model. Biological Psychiatry: Global Open Science, 3(3), 500-509. https://doi.org/10.1016/j.bpsgos.2022.05.004

Sigurdsson, B., Hauglund, N. L., Lilius, T. O., Mogensen, F. L. H., Mortensen, K. N., Beschorner, N., Klinger, L., Bærentzen, S. L., Rosenholm, M. P., Shalgunov, V., Herth, M., Mori, Y. & Nedergaard, M. (2023). A SPECT-based method for dynamic imaging of the glymphatic system in rats. Journal of Cerebral Blood Flow and Metabolism, 43(7), 1153 - 1165. https://doi.org/10.1177/0271678X231156982

Shyamsundar, G., Raghuthaman, G., Rajamani, A. P. R. & Jacob, K. S. (2009). Validation of memorial delirium assessment scale. South African Journal of Critical Care, 24(4), 530-4. https://doi.org/10.1016/j.jcrc.2008.12.016

Shiadeh, S. M. J., Goretta, F., Svedin, P., Jansson, T., Mallard, C. & Ardalan, M. (2024). Long-term impact of maternal obesity on the gliovascular unit and ephrin signaling in the hippocampus of adult offspring. Journal of Neuroinflammation, 21(1). https://doi.org/10.1186/s12974-024-03030-w

Shi, Y., Pedersen, M., Li, C., Wen, J. G., Thomsen, K., Stødkilde-Jørgensen, H., Jørgensen, T. M., Knepper, M. A., Nielsen, S., Djurhuus, J. C. & Frøkiær, J. (2004). Early release of neonatal ureteral obstruction preserves renal function. American Journal of Physiology: Renal Physiology, 286(6), 1087-1099. https://doi.org/10.1152/ajprenal.00201.2003

Shi, Y., Thomsen, K., Knepper, M. A. & Frøkiær, J. (2006). Renal clearance of 99mTc-DTPA underestimates glomerular filtration rate as compared with renal clearance of 3H-inulin or 51Cr-EDTA. Manuscript submitted for publication.

Sher, L., Stanley, B. H., Carballo, J. J., Brent, D., Arendt, M., Harkavy-Friedman, J., Sperling, D., Lizardi, D., Mann, J. J. & Oquendo, M. A. (2008). Depressed patients with co-occuring alcohol use disorders: a unique patient population. Journal of Clinical Psychiatry, 69(6), 907-915.

Shelton, M. A., Newman, J. T., Gu, H., Sampson, A. R., Fish, K. N., MacDonald, M. L., Moyer, C. E., DiBitetto, J. V., Dorph-Petersen, K.-A., Penzes, P., Lewis, D. A. & Sweet, R. A. (2015). Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. Biological Psychiatry, 78, 374-385. https://doi.org/10.1016/j.biopsych.2014.12.029

Shelton, M. A., Newman, J. T., Gu, H., Sampson, A. R., Fish, K. N., MacDonald, M. L., Moyer, C. E., DiBitetto, J. V., Dorph-Petersen, K.-A., Penzes, P., Lewis, D. A. & Sweet, R. A. (2015). Loss of MAP2 Immunoreactivity correlates to Dendritic Spine Loss in Schizophrenia. Poster session presented at Psykiatriens 10. forskningsdag, Risskov, Denmark.

Shelton, M. A., Newman, J. T., Fish, K. N., Dorph-Petersen, K.-A., Penzes, P., Lewis, D. A. & Sweet, R. A. (2014). Schizophrenia-associated alterations of microtubule associated protein 2 in human auditory cortex. Poster session presented at Psykiatriens 9. forskningsdag.

Sharma, N., Hollensen, A. K., Bak, R. O., Staunstrup, N. H., Schrøder, L. D. & Mikkelsen, J. G. (2012). The Impact of cHS4 Insulators on DNA Transposon Vector Mobilization and Silencing in Retinal Pigment Epithelium Cells. PLOS ONE, 7(10). https://doi.org/10.1371/journal.pone.0048421

Shabani, M., Nazeri, M., Ghahrechahi, H.-R., Pourzare, A., Abareghi, F., Samiee-Rad, S., Arjmand, S. & Abazarpour, R. (2018). Role of anxiety and depression in association with migraine and myofascial pain temporomandibular disorder. Indian Journal of Dental Research, 29(5), 583. https://doi.org/10.4103/0970-9290.244932

Severinsen, J., Als, T. D., Binderup, H., Wang, AG., Kruse, TA., Muir, WJ., Blackwood, DH., Mors, O. & Børglum, A. (2005). Association analysis suggesting GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia. Abstract from XIII World Congress on Psychiatric Genetics 2005 Boston, USA.

Severinsen, J., Als, T. D., Binderup, H., Kruse, T. A., Wang, A. G., Muir, W. J., Blackwood, D. H. R., Mors, O. & Børglum, A. (2006). Association analyses suggest GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 141B, 524-533.

Severinsen, J., Bjarkam, C., Kiær-Larsen, S., Olsen, I. M., Nielsen, M. M., Blechingberg, J., Nielsen, A. L., Holm, I. E., Foldager, L., Young, B. D., Muir, W. J., Blackwood, D. HR., Corydon, T. J., Mors, O. & Børglum, A. (2006). Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Molecular Psychiatry, 1126-1138. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16924267&itool=iconabstr&query_hl=1&itool=pubmed_docsum

Severinsen, J., Bjarkam, C., Kiær-Larsen, S., Olsen, I. M., Nielsen, M. M., Blechingberg, J., Nielsen, A. L., Holm, I. E., Foldager, L., Young, B. D., Muir, W. J., Blackwood, D. HR., Corydon, T. J., Mors, O. & Børglum, A. (2006). Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.. Abstract from XlV World Congress on Psychiatric Genetics, Caliari, Italy.

Severinsen, J., Binderup, H., Mors, O., Wang, A. G., Vang, M., Murray, V., Muir, W., Mckee, I., Kruse, T. A., Blackwood, D. HR., Ewald, H. & Børglum, A. (2002). Association study of candidate genes for susceptibility to schizophrenia and bipolar disorder on chromosome 22Q13. Abstract from X World Congress on Psychiatric Genetics, 2002, Bruxelles, Belgium.

Severinsen, J., Nyegaard, M., Bjarkam, C., Corydon, T. J., Olsen, I. M., Straarup, S., Nordentoft, M., Gurling, H. M., Mors, O. & Børglum, A. (2008). Support for BRD1 as a suspectibility gene for both schizophrenia and bipolar affective disorder. Abstract from World Congress on Psychiatric Genetics XV, New York, United States.

Severinsen, K., Müller, H. K., Wiborg, O. & Sinning, S. (2008). Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2008.05285.x

Displaying results 401 to 450 out of 2448

Revised 06.02.2023

Karen Jul Madsen